{"id":"https://openalex.org/W2005270107","doi":"https://doi.org/10.1097/qad.0b013e3280b07b33","title":"The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years","display_name":"The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years","publication_year":2007,"publication_date":"2007-06-01","ids":{"openalex":"https://openalex.org/W2005270107","doi":"https://doi.org/10.1097/qad.0b013e3280b07b33","mag":"2005270107","pmid":"https://pubmed.ncbi.nlm.nih.gov/17545703"},"language":"en","primary_location":{"id":"doi:10.1097/qad.0b013e3280b07b33","doi":"https://doi.org/10.1097/qad.0b013e3280b07b33","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qad.0b013e3280b07b33","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005270107"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103169075","display_name":"Mark Richard Nelson","orcid":"https://orcid.org/0000-0002-5944-6096","observed_orcids":["https://orcid.org/0000-0002-5944-6096"]},"institutions":[{"id":"https://openalex.org/I2799869770","display_name":"Chelsea and Westminster Hospital NHS Foundation Trust","ror":"https://ror.org/02gd18467","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799869770"]},{"id":"https://openalex.org/I4210136304","display_name":"Chelsea and Westminster Hospital","ror":"https://ror.org/038zxea36","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799869770","https://openalex.org/I4210136304"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Mark R Nelson","raw_affiliation_strings":["Department of HIV and Genitourinary Medicine, Chelsea and Westminster Hospital, 369 Fulham Road, London, UK. mark.nelson@chelwest.nhs.uk","Department of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of HIV and Genitourinary Medicine, Chelsea and Westminster Hospital, 369 Fulham Road, London, UK. mark.nelson@chelwest.nhs.uk","institution_ids":["https://openalex.org/I2799869770","https://openalex.org/I4210136304"]},{"raw_affiliation_string":"Department of","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017386021","display_name":"Christine Katlama","orcid":"https://orcid.org/0000-0002-5093-4800","observed_orcids":["https://orcid.org/0000-0002-5093-4800"]},"institutions":[{"id":"https://openalex.org/I4210121705","display_name":"Piti\u00e9-Salp\u00eatri\u00e8re Hospital","ror":"https://ror.org/02mh9a093","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210121705"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christine Katlama","raw_affiliation_strings":["Department of Infectious Diseases, Pitie-Salpetriere Hospital, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Pitie-Salpetriere Hospital, Paris, France","institution_ids":["https://openalex.org/I4210121705"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Julio S Montaner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julio S Montaner","raw_affiliation_strings":["British Columbia Centre for Excellence in"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"British Columbia Centre for Excellence in","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111965256","display_name":"David A. Cooper","orcid":"https://orcid.org/0000-0002-1345-2546","observed_orcids":["https://orcid.org/0000-0002-1345-2546"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David A Cooper","raw_affiliation_strings":["National Centre in"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Centre in","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110215411","display_name":"Brian Gazzard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian Gazzard","raw_affiliation_strings":["Department of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028130303","display_name":"Bonaventura Clotet","orcid":"https://orcid.org/0000-0003-3232-4598","observed_orcids":["https://orcid.org/0000-0003-3232-4598"]},"institutions":[{"id":"https://openalex.org/I4210153460","display_name":"Hospital Universitari Germans Trias i Pujol","ror":"https://ror.org/04wxdxa47","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210153292","https://openalex.org/I4210153460"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Bonaventura Clotet","raw_affiliation_strings":["Hospital Universitari Germans Trias i Pujol and Institut de Recerca de la SIDA-Caixa Foundation, Badalona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitari Germans Trias i Pujol and Institut de Recerca de la SIDA-Caixa Foundation, Badalona, Spain","institution_ids":["https://openalex.org/I4210153460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021984756","display_name":"Adriano Lazzarin","orcid":"https://orcid.org/0000-0003-2551-7754","observed_orcids":["https://orcid.org/0000-0003-2551-7754"]},"institutions":[{"id":"https://openalex.org/I154387261","display_name":"Vita-Salute San Raffaele University","ror":"https://ror.org/01gmqr298","country_code":"IT","type":"education","lineage":["https://openalex.org/I154387261"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Adriano Lazzarin","raw_affiliation_strings":["Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy","institution_ids":["https://openalex.org/I154387261"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036208925","display_name":"Knud Schewe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Knud Schewe","raw_affiliation_strings":["IPM-Study Centre, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IPM-Study Centre, Hamburg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113507629","display_name":"Joep M. A. Lange","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Joep Lange","raw_affiliation_strings":["Center for Poverty-Related Communicable Diseases, Academic Medical Center, University of Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Poverty-Related Communicable Diseases, Academic Medical Center, University of Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I887064364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109434145","display_name":"Christina M. Wyatt","orcid":"https://orcid.org/0000-0002-2900-8140","observed_orcids":["https://orcid.org/0000-0002-2900-8140"]},"institutions":[{"id":"https://openalex.org/I1324220072","display_name":"Mount Sinai Hospital","ror":"https://ror.org/01zkyz108","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1320796813","https://openalex.org/I1324220072"]},{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christina Wyatt","raw_affiliation_strings":["Division of Nephrology, Mount Sinai Medical Center, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Nephrology, Mount Sinai Medical Center, New York, USA","institution_ids":["https://openalex.org/I1324220072","https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044826864","display_name":"Sue Curtis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106787","display_name":"Gilead Sciences (United Kingdom)","ror":"https://ror.org/01e11zd27","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210106787","https://openalex.org/I4210140816"]},{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Sue Curtis","raw_affiliation_strings":["Gilead Sciences, Inc., Cambridge, UK and Foster City, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Inc., Cambridge, UK and Foster City, California, USA","institution_ids":["https://openalex.org/I4210106787","https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109168426","display_name":"Shan-Shan Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106787","display_name":"Gilead Sciences (United Kingdom)","ror":"https://ror.org/01e11zd27","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210106787","https://openalex.org/I4210140816"]},{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Shan-Shan Chen","raw_affiliation_strings":["Gilead Sciences, Inc., Cambridge, UK and Foster City, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Inc., Cambridge, UK and Foster City, California, USA","institution_ids":["https://openalex.org/I4210106787","https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Stephen Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106787","display_name":"Gilead Sciences (United Kingdom)","ror":"https://ror.org/01e11zd27","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210106787","https://openalex.org/I4210140816"]},{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Stephen Smith","raw_affiliation_strings":["Gilead Sciences, Inc., Cambridge, UK and Foster City, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Inc., Cambridge, UK and Foster City, California, USA","institution_ids":["https://openalex.org/I4210106787","https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109308112","display_name":"Norbert Bischofberger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106787","display_name":"Gilead Sciences (United Kingdom)","ror":"https://ror.org/01e11zd27","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210106787","https://openalex.org/I4210140816"]},{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Norbert Bischofberger","raw_affiliation_strings":["Gilead Sciences, Inc., Cambridge, UK and Foster City, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Inc., Cambridge, UK and Foster City, California, USA","institution_ids":["https://openalex.org/I4210106787","https://openalex.org/I4210140816"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049620208","display_name":"James F. Rooney","orcid":"https://orcid.org/0000-0003-3261-0711","observed_orcids":["https://orcid.org/0000-0003-3261-0711"]},"institutions":[{"id":"https://openalex.org/I2799869770","display_name":"Chelsea and Westminster Hospital NHS Foundation Trust","ror":"https://ror.org/02gd18467","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799869770"]},{"id":"https://openalex.org/I4210106787","display_name":"Gilead Sciences (United Kingdom)","ror":"https://ror.org/01e11zd27","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210106787","https://openalex.org/I4210140816"]},{"id":"https://openalex.org/I4210136304","display_name":"Chelsea and Westminster Hospital","ror":"https://ror.org/038zxea36","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799869770","https://openalex.org/I4210136304"]},{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"James F Rooney","raw_affiliation_strings":["Gilead Sciences, Inc., Cambridge, UK and Foster City, California, USA","to Dr M.R. Nelson, Chelsea and Westminster Hospital, 369 Fulham Rd, London SW10 9NH, UK. E-mail: [email\u00a0protected]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Inc., Cambridge, UK and Foster City, California, USA","institution_ids":["https://openalex.org/I4210106787","https://openalex.org/I4210140816"]},{"raw_affiliation_string":"to Dr M.R. Nelson, Chelsea and Westminster Hospital, 369 Fulham Rd, London SW10 9NH, UK. E-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I2799869770","https://openalex.org/I4210136304"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5103169075"],"corresponding_institution_ids":["https://openalex.org/I2799869770","https://openalex.org/I4210136304"],"apc_list":null,"apc_paid":null,"fwci":17.7909,"has_fulltext":false,"cited_by_count":376,"citation_normalized_percentile":{"value":0.99602337,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"21","issue":"10","first_page":"1273","last_page":"1281"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tenofovir-disoproxil-fumarate","display_name":"tenofovir disoproxil fumarate","score":1.0},{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.9800000190734863},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.828000009059906},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.9829999804496765},{"id":"https://openalex.org/keywords/nephrotoxicity","display_name":"nephrotoxicity","score":0.9710000157356262},{"id":"https://openalex.org/keywords/renal-adverse-events","display_name":"renal adverse effects","score":0.8199999928474426},{"id":"https://openalex.org/keywords/creatinine-elevation","display_name":"creatinine elevation","score":0.9039999842643738},{"id":"https://openalex.org/keywords/serious-adverse-drug-reactions","display_name":"serious adverse drug reactions","score":0.6880000233650208},{"id":"https://openalex.org/keywords/bone-abnormalities","display_name":"bone abnormalities","score":0.7760000228881836},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.8009999990463257},{"id":"https://openalex.org/keywords/expanded-access-program","display_name":"expanded access program","score":0.7540000081062317},{"id":"https://openalex.org/keywords/post-marketing-surveillance","display_name":"post-marketing surveillance","score":0.9390000104904175}],"concepts":[{"id":"https://openalex.org/C197636746","wikidata":"https://www.wikidata.org/wiki/Q7234359","display_name":"Postmarketing surveillance","level":3,"score":0.7857699990272522},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7783656120300293},{"id":"https://openalex.org/C126189478","wikidata":"https://www.wikidata.org/wiki/Q1468324","display_name":"Nephrotoxicity","level":3,"score":0.7318180203437805},{"id":"https://openalex.org/C2779344132","wikidata":"https://www.wikidata.org/wiki/Q155954","display_name":"Tenofovir","level":3,"score":0.6723642349243164},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.6519871950149536},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6273266673088074},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5169653296470642},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.4742285907268524},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3231314420700073},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.3073831796646118},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.17278528213500977},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.16133961081504822}],"mesh":[{"descriptor_ui":"D000068698","descriptor_name":"Tenofovir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003404","descriptor_name":"Creatinine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007674","descriptor_name":"Kidney Diseases","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007674","descriptor_name":"Kidney Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011358","descriptor_name":"Product Surveillance, Postmarketing","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018791","descriptor_name":"CD4 Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D044966","descriptor_name":"Anti-Retroviral Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D063065","descriptor_name":"Organophosphonates","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1097/qad.0b013e3280b07b33","doi":"https://doi.org/10.1097/qad.0b013e3280b07b33","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qad.0b013e3280b07b33","pdf_url":null,"source":{"id":"https://openalex.org/S20605092","display_name":"AIDS","issn_l":"0269-9370","issn":["0269-9370","1473-5571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS","raw_type":"journal-article"},{"id":"pmid:17545703","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17545703","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS (London, England)","raw_type":"Journal Article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/5cb99461-b61f-46ea-ba23-4101c9d276b5","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/the-safety-of-tenofovir-disoproxil-fumarate-for-the-treatment-of-hiv-infection-in-adults-the-first-4-years(5cb99461-b61f-46ea-ba23-4101c9d276b5).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"AIDS (London, England), 21(10), 1273 - 1281. Lippincott Williams and Wilkins","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/f1ac169e-89c6-4132-aadb-c030c0f9717d","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/f1ac169e-89c6-4132-aadb-c030c0f9717d","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Nelson, M R, Katlama, C, Montaner, J S, Cooper, D A, Gazzard, B, Clotet, B, Lazzarin, A, Schewe, K, Lange, J, Wyatt, C, Curtis, S, Chen, S-S, Smith, S, Bischofberger, N & Rooney, J F 2007, 'The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years', AIDS (London, England), vol. 21, no. 10, pp. 1273-1281. https://doi.org/10.1097/QAD.0b013e3280b07b33","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W1511422150","https://openalex.org/W1550111394","https://openalex.org/W1968789632","https://openalex.org/W1975274424","https://openalex.org/W1987818325","https://openalex.org/W1994059773","https://openalex.org/W1996313031","https://openalex.org/W2004567313","https://openalex.org/W2018564409","https://openalex.org/W2020692439","https://openalex.org/W2022552811","https://openalex.org/W2023206926","https://openalex.org/W2026158691","https://openalex.org/W2047128784","https://openalex.org/W2053407562","https://openalex.org/W2055483238","https://openalex.org/W2055864845","https://openalex.org/W2056779298","https://openalex.org/W2082809244","https://openalex.org/W2088942634","https://openalex.org/W2107027814","https://openalex.org/W2110937893","https://openalex.org/W2111980395","https://openalex.org/W2129025092","https://openalex.org/W2140648515","https://openalex.org/W2140782253","https://openalex.org/W2142285241","https://openalex.org/W2151425917","https://openalex.org/W2159686293","https://openalex.org/W2161193921","https://openalex.org/W2165687042"],"related_works":["https://openalex.org/W2766583960","https://openalex.org/W2039605867","https://openalex.org/W1987818325","https://openalex.org/W1987159522","https://openalex.org/W2142285241","https://openalex.org/W1968789632","https://openalex.org/W2010542260","https://openalex.org/W131994380","https://openalex.org/W2162761942","https://openalex.org/W166029327"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"characterize":[2,70],"the":[3,12,20,47,71,115,126,162,183,192,195,221],"safety":[4,38,73,152,197,207,215],"profile":[5,216],"of":[6,14,24,53,74,96,103,114,128,157,223,232],"tenofovir":[7,28,75,160,218],"disoproxil":[8],"fumarate":[9],"(DF)":[10],"for":[11,125,217,230],"treatment":[13,222],"HIV":[15,226],"infection":[16],"in":[17,36,90,101,108,112,182,190,205,220,241],"adults":[18,224],"over":[19],"first":[21],"4":[22],"years":[23],"use.":[25],"METHODS:":[26],"A":[27,93],"DF":[29,219],"expanded":[30],"access":[31],"program":[32,44],"(EAP)":[33],"was":[34,99],"initiated":[35],"2001;":[37],"data":[39,153,211],"were":[40,67,88,133,170,187,203],"examined":[41],"from":[42,46],"this":[43],"and":[45,105,145,237],"manufacturer's":[48],"database,":[49],"which":[50],"contained":[51],"reports":[52],"all":[54],"postmarketing":[55,151,196,206],"adverse":[56,85,167],"drug":[57,168],"reactions":[58,169],"received":[59],"up":[60],"to":[61,69,159,179],"30":[62],"April":[63],"2005.":[64],"Specific":[65],"analyses":[66],"performed":[68],"renal":[72,94,171],"DF.":[76],"RESULTS:":[77],"The":[78,210],"EAP":[79,193],"enrolled":[80],"10":[81],"343":[82],"patients;":[83],"serious":[84,166],"events":[86],"(SAEs)":[87],"reported":[89,165,189],"631":[91],"(6%).":[92],"SAE":[95],"any":[97],"type":[98,177],"observed":[100,181],"0.5%":[102],"patients,":[104],"graded":[106],"elevations":[107],"serum":[109,130,135],"creatinine":[110,131],"occurred":[111],"2.2%":[113],"patients":[116,244],"evaluated.":[117],"In":[118],"a":[119,174,213],"multivariate":[120],"analysis,":[121],"baseline":[122],"risk":[123],"factors":[124,229],"development":[127,231],"increased":[129],"on-study":[132],"elevated":[134],"creatinine,":[136],"concomitant":[137],"nephrotoxic":[138],"medications,":[139],"low":[140],"body":[141],"weight,":[142],"advanced":[143],"age,":[144],"lower":[146],"CD4":[147],"cell":[148],"count.":[149],"For":[150],"(455":[154],"392":[155],"person-years":[156],"exposure":[158],"DF)":[161],"most":[163],"commonly":[164],"events,":[172],"with":[173,225],"distribution":[175],"by":[176],"similar":[178],"that":[180],"EAP.":[184],"Bone":[185],"abnormalities":[186],"infrequently":[188],"either":[191],"or":[194],"databases.":[198],"No":[199],"new":[200],"unexpected":[201],"toxicities":[202],"identified":[204,236],"surveillance.":[208],"CONCLUSIONS:":[209],"demonstrate":[212],"favorable":[214],"infection.":[227],"Risk":[228],"nephrotoxicity":[233],"can":[234],"be":[235,239],"may":[238],"useful":[240],"managing":[242],"those":[243],"at":[245],"greatest":[246],"risk.":[247]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":16},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":16},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":17},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":17},{"year":2017,"cited_by_count":26},{"year":2016,"cited_by_count":25},{"year":2015,"cited_by_count":23},{"year":2014,"cited_by_count":26},{"year":2013,"cited_by_count":30},{"year":2012,"cited_by_count":30}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
